Episode 189: From Apartheid to Abraxane with Dr. Soon-Shiong

In this exclusive interview on Healthcare Unfiltered, I welcome Dr. Patrick Soon-Shiong, a Chinese immigrant who grew up under apartheid in South Africa and rose to become one of the world’s most successful physician executives. Now the CEO of ImmunityBio, Dr. Soon-Shiong opens up about his remarkable journey. He shares what inspired him to pursue medicine, his entrepreneurial ventures, his move to the United States, and the story of his first investment. He also discusses creating the groundbreaking chemotherapy drug Abraxane, which led to the formation of Abraxis, later acquired by Celgene, now part of BMS. And his most recent FDA-approved drug Anktiva for bladder cancer.

With complete candidness, Dr. Soon-Shiong reflects on his challenging upbringing, the discrimination he faced, and how he overcame these obstacles to achieve great success. We explore life lessons, leadership styles, and a range of topics including Kobe Bryant, Gavin Newsom, COVID, the first pancreatic transplant, the acquisition of the Los Angeles Times, and his public feud with his brother. This 2024 podcast episode offers an unparalleled glimpse into the life of a highly public and inspiring figure and is one you’ll want to listen to more than once and share with everyone you know.

 

Related Resources

Subscribe to Healthcare Unfiltered

Other Episodes You May Enjoy...

Episode 206: Fireside Chat With Joe Mikhael, the CMO of the IMF

Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding

Read More

Episode 205: Multi-Cancer Early Detection (MCED): Now and Later

Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary

Read More